| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/29/2011 | EP2339008A1 Basal transcription factors silencing to induce recoverable male sterility in plants |
| 06/29/2011 | EP2339007A1 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use |
| 06/29/2011 | EP2339006A2 DNA constructs for expression of heterologous polypeptides in plants |
| 06/29/2011 | EP2339005A2 DNA constructs for expression of heterologous polypeptides in plants |
| 06/29/2011 | EP2339004A1 Optimizing glycan processing in plants |
| 06/29/2011 | EP2339003A2 APO-2 ligand substitutional variants |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2339001A2 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2339000A1 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338999A2 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338998A1 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338997A1 Method for isolation of soluble polypeptides |
| 06/29/2011 | EP2338996A2 Methods and compositions for reducing viral genome amounts in a target cell |
| 06/29/2011 | EP2338995A2 Interfering RNA duplex having blunt-ends and 3'-modifications |
| 06/29/2011 | EP2338994A1 Regulation of oncogenes by microRNAs |
| 06/29/2011 | EP2338993A1 Regulation of oncogenes by microRNAs |
| 06/29/2011 | EP2338992A2 Antisense compounds having enhanced anti-microRNA activity |
| 06/29/2011 | EP2338991A2 Methods for use in modulating MIR-122a |
| 06/29/2011 | EP2338990A2 Methods for synthesis of encoded libraries |
| 06/29/2011 | EP2338989A1 Method for preparing fecal sample, fecal sample preparation solution, and feces collection kit |
| 06/29/2011 | EP2338988A1 Evaluation/screening method for diseases associated with d-amino acid utilizing dao1-/- mouse |
| 06/29/2011 | EP2338986A1 Novel lipases and uses thereof |
| 06/29/2011 | EP2338984A1 Synthetic viruses and uses thereof |
| 06/29/2011 | EP2338978A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/29/2011 | EP2338974A2 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
| 06/29/2011 | EP2338915A2 Anti-VEGF antibodies |
| 06/29/2011 | EP2338913A1 Chromosome 13-linked breast cancer susceptibility gene |
| 06/29/2011 | EP2338911A1 Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells |
| 06/29/2011 | EP2338909A1 Modified peptide of human acidic fibroblast growth factor |
| 06/29/2011 | EP2338905A2 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338895A1 Genetically modified yeast species and fermentation processes using genetically modified yeast |
| 06/29/2011 | EP2338894A1 Flavivirus fusion inhibitors |
| 06/29/2011 | EP2338893A1 Labelled nucleotides |
| 06/29/2011 | EP2338519A1 Agent for treating myelofibrosis |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338512A1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/29/2011 | EP2338508A1 A rDEN3/4delta 30(ME), rDEN2/4delta30(ME) or rDEN1/4delta30(ME) recombinant chimeric dengue virus containing a 30 nucleotide deletion (delta30) in a section of the 3' untranslated region of dengue type 4 genome, wherein said 30 nucleotide deletion corresponds to the TL2 stem-loop structure. |
| 06/29/2011 | EP2338505A2 Vault and vault-like carrier molecules |
| 06/29/2011 | EP2338504A2 Vault and vault-like carrier molecules |
| 06/29/2011 | EP2338328A2 Certain plants with no saturate or reduced saturate levels of fatty acids in seeds, and oil derived from the seeds |
| 06/29/2011 | EP2337856A1 INCREASED HETEROLOGOUS Fe-S ENZYME ACTIIVTY IN YEAST |
| 06/29/2011 | EP2337854A2 New tomato ethylene response factors and uses thereof |
| 06/29/2011 | EP2337853A1 Plants with increased yield (lt) |
| 06/29/2011 | EP2337852A2 Methods and compositions for isolating nucleic acid |
| 06/29/2011 | EP2337850A2 Anti-protozoa compounds |
| 06/29/2011 | EP2337849A1 Factor ix polypeptide mutant, its uses and a method for its production |
| 06/29/2011 | EP2337848A1 Modification of fructan biosynthesis, increasing plant biomass, and enhancing productivity of biochemical pathways in a plant |
| 06/29/2011 | EP2337798A1 Bsa-specific antibodies |
| 06/29/2011 | EP2337791A1 Utilization of fatty acid desaturases from hemiselmis spp |
| 06/29/2011 | EP2337789A2 Genus-wide chlamydial peptide vaccine antigens |
| 06/29/2011 | EP2337582A1 Bovine herpes virus -1 compositions, vaccines and methods |
| 06/29/2011 | EP2337581A1 Synthetic gene construct encoding an hiv-1 gag and the use thereof for obtaining anti-hiv-1 vaccines |
| 06/29/2011 | EP2021472B1 Compounds and methods for modulating gene expression |
| 06/29/2011 | EP1991675B1 End modification to prevent over-representation of fragments |
| 06/29/2011 | EP1970382B1 Activated collagen scaffold materials and their special fused active restoration factors |
| 06/29/2011 | EP1941025B1 Use of fungal mutants for expression of antibodies |
| 06/29/2011 | EP1799825B1 Aptamer regulated nucleic acids and uses thereof |
| 06/29/2011 | EP1781690B1 Transgenic mouse models of hepatitis c virus (hcv) and identification of hcv therapeutics |
| 06/29/2011 | EP1743029B1 Cell preparation |
| 06/29/2011 | EP1694850B1 Plasmid system for multigene expression |
| 06/29/2011 | EP1641944B1 Room temperature elution of nucleic acids |
| 06/29/2011 | EP1641930B1 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 06/29/2011 | EP1613661B1 Peptabody for cancer treatment |
| 06/29/2011 | EP1576014B1 Antibodies against pd-1 and uses thereof |
| 06/29/2011 | EP1537142B1 Akap18 delta, a novel splicing variant of a protein kinase a anchor protein and the use of the same |
| 06/29/2011 | EP1523496B1 Recombinant production of mixtures of antibodies |
| 06/29/2011 | EP1504036B1 Toxin-related fragments of antibodies with antimicrobial and antiviral activity |
| 06/29/2011 | EP1503788B1 Treatment of alpha-galactosidase a deficiency |
| 06/29/2011 | EP1183348B1 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 06/29/2011 | EP1181323B1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
| 06/29/2011 | EP1164190B1 Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis |
| 06/29/2011 | EP1151126B1 Biocatalytic synthesis of shikimic acid |
| 06/29/2011 | EP1114151B1 G protein-coupled receptor antagonists |
| 06/29/2011 | CN1918298B Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation |
| 06/29/2011 | CN1875111B Production of high mannose proteins in plant culture |
| 06/29/2011 | CN1863923B Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
| 06/29/2011 | CN1842602B Modified vaccinia virus ankara (MVA) mutant and use thereof |
| 06/29/2011 | CN1768143B Method for expression of interference gene in plant |
| 06/29/2011 | CN1606565B Nucleic acids encoding recominant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 06/29/2011 | CN1427889B Hybrid cells obtainable from antigen presenting cells |
| 06/29/2011 | CN102112878A Device for detection of influenza virus |
| 06/29/2011 | CN102112628A Method for detecting chromosome deficiencies for congenital abnormality |
| 06/29/2011 | CN102112625A Method of distinguishing inflammatory pathogen causing acute respiratory infection |
| 06/29/2011 | CN102112616A System for packaging high-capacity adenoviruses |
| 06/29/2011 | CN102112615A Plant expression constructs and uses thereof |
| 06/29/2011 | CN102112614A Compositions and methods of use of mitogen-activated protein kinase kinase kinase |
| 06/29/2011 | CN102112612A Variant hhip1 protein and methods and uses thereof |
| 06/29/2011 | CN102112611A Novel protease and use thereof |
| 06/29/2011 | CN102112610A Plant having increased grain size which contains sh4 gene |
| 06/29/2011 | CN102112606A Constructs and methods for the production and secretion of polypeptides |
| 06/29/2011 | CN102112605A Variant alpha-amylases from bacillus subtilis and methods of use, thereof |
| 06/29/2011 | CN102112602A Detergent composition comprising lipase |
| 06/29/2011 | CN102112601A Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 06/29/2011 | CN102112596A Development of strains of thermotolerant yeast hansenula polymorpha capable of alcoholic fermentation of starch and xylan by expression of starch and xylan degrading enzymes |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112492A Diagnosis and treatment of cancer using anti-GPR49 antibody |
| 06/29/2011 | CN102112150A Yeast strain for the production of proteins with terminal alpha-1, 3-linked galactose |
| 06/29/2011 | CN102112146A Immunity inducer |